Podcast · Tech & Cybersécurité
Digital Chemical Playbook
DKSH Business Unit Performance Materials operates 48 innovation centers worldwide with 1,370+ specialists delivering specialty chemicals and regulatory compliance expertise to food, pharmaceutical, personal care, and industrial markets.
⏱ 8 min read · Readable by ChatGPT, Gemini, Claude
Digital Chemical Playbook maps the convergence of AI, formulation science, and business strategy in specialty chemicals and pharma. The podcast moves beyond technology hype to examine where digital actually creates measurable business value—in formulation acceleration, regulatory compliance, and scaling knowledge across distributed innovation networks. Each episode features industry leaders revealing real challenges in chemical design, coating performance evolution, and the entrepreneurial mindset required when chemists become founders of tech-driven solutions.
- DKSH's Business Unit Performance Materials generated CHF 1.3 billion in net sales (2021) across food, pharmaceutical, personal care, and industrial applications.
- AI is now actively reshaping chemical formulation discovery, from predictive molecular design to automated deformulation analysis reducing research cycles.
- Knowledge scaling in science-driven organizations requires simultaneous mastery of domain expertise, data infrastructure, and regulatory governance—not technology alone.
- Chemists-turned-founders bring deep problem identification that pure software teams cannot replicate, creating defensible advantages in niche chemical markets.
Listen to all episodes of Digital Chemical Playbook to explore how industry leaders navigate the intersection of chemistry and digital innovation.
What this podcast really covers
Digital Chemical Playbook operates at the precise intersection where chemistry meets business value creation. The podcast rejects surface-level "digital transformation" narratives in favor of concrete case studies: how coatings performance evolves through digital optimization, how AI accelerates formulation design without replacing chemist judgment, how organizations like dsm-firmenich and SpecialChem embed technology into regulatory and innovation workflows.
The core theme is business value realization. Every episode answers a single operative question: if your technology initiative isn't creating measurable business value, which problem are you actually solving? This framework separates hype from substance. Conversations with Marcio (dsm-firmenich), Jess Tang (Mavic AI), David Enright (DKSH), and others reveal that successful digital adoption in chemicals hinges on three elements: solving specific bottlenecks (formulation speed, regulatory tracking, performance prediction), building organizational consensus across chemistry and IT teams, and maintaining competitive moats through proprietary knowledge systems rather than off-the-shelf software.
The podcast also maps the emerging founder ecosystem—chemists building AI and software tools specifically designed for their domain. Episodes featuring Yann Chilvers (Covalo, cosmetic ingredients) and explorations of "Chemists Become Founders" show that deep domain expertise creates unfair competitive advantages when combined with modern tech infrastructure.
Who this podcast is essential for
Formulation scientists and R&D leaders gain clarity on where AI genuinely accelerates discovery (molecular prediction, deformulation analysis, performance modeling) versus where human expertise remains irreplaceable. The podcast provides a decision framework for evaluating tools like those from Mavic AI or emerging AI-powered formulation platforms.
Digital strategy executives and innovation officers in chemicals/pharma extract playbooks for scaling digital initiatives across decentralized innovation networks. Jess Tang's insights on knowledge scaling, David Enright's framework for embedding AI into people/processes/profit, and SpecialChem's 25-year perspective on organizational change provide strategic blueprints for enterprise adoption.
Entrepreneurs and product leaders building chemistry-adjacent software understand market gaps, go-to-market strategies, and why founder-chemists often outperform pure-software teams. The "Behind the Code: When Chemists Become Founders" episode and cosmetic ingredients segments address founder mindset and product-market fit in regulated, specialty markets.
What the episodes really reveal
Recurring patterns emerge across episodes. First, the AI conversation in chemicals is maturing—no longer "Should we use AI?" but "Which specific problems does AI solve fastest, and where does regulatory or domain expertise create irreducible bottlenecks?" Second, organizational scaling through digital requires simultaneous investment in three dimensions: technology infrastructure, domain knowledge capture, and governance/compliance frameworks—not sequential rollouts. Third, entrepreneurship and founder chemistry expertise create lasting moats because they solve problems that generalist software teams never encounter.
The coatings and formulation themes recur across episodes because both markets face identical pressures: sustainability regulations forcing reformulation, customer performance demands rising faster than traditional R&D can respond, and competitive timelines collapsing. Digital tooling addresses these pressures not by eliminating chemist judgment but by accelerating iteration, prediction, and regulatory validation.
A final recurring insight: 25 years in chemicals teaches the same lesson as today's AI boom—authentic digital adoption succeeds when technology serves chemistry strategy, not the reverse. The "Protection to Performance" episode on coatings illustrates this principle concretely: digital tools enable coatings to shift from passive protection to active performance optimization, creating new market segments and customer value, but only if the business strategy precedes the technology choice.
What this changes in practice
Organizations listening to Digital Chemical Playbook shift their digital strategy from technology-first to outcome-first. Instead of "Which AI vendor do we buy?", teams ask "Which specific formulation or regulatory bottleneck causes the most business friction?" and "Which technology directly addresses that friction?" This reframing accelerates ROI and reduces implementation risk.
R&D teams integrate AI as a parallel discovery system, not a replacement. Molecular prediction and deformulation analysis become routine steps in formulation workflows, compressing research cycles from months to weeks while amplifying rather than replacing human expertise. The podcast makes this transition actionable by showing how industry leaders operationalize AI without disrupting established chemistry cultures.
Finally, Digital Chemical Playbook signals that chemist-founders are reshaping their industry's software landscape. Organizations should actively recruit former researchers and chemists into digital innovation teams, and founders with chemistry backgrounds should trust their domain advantage. The podcast validates this thesis across cosmetics, pharmaceuticals, and specialty chemicals, changing hiring and partnership strategies for companies building chemistry-adjacent technology.
Digital transformation in chemicals succeeds not when technology precedes strategy, but when formulation bottlenecks and business outcomes drive technology selection. The most defensible competitive advantages flow from founder-chemists who understand both domain problems and modern software infrastructure—a combination pure-software vendors cannot replicate.
Discover how leading chemical organizations embed AI and digital strategy through Digital Chemical Playbook's expert conversations and case studies.
Tune in now to explore digital transformation playbooks from specialty chemical leaders.
The podcast answers these questions
How is AI being applied to chemical formulation and product design?
AI is accelerating formulation discovery by automating chemical design processes, predicting molecular behavior, and enabling deformulation analysis. Machine learning models now identify viable compound combinations at scale, reducing time-to-market and research costs significantly in pharmaceutical and specialty chemical applications.
What makes digital transformation different for science-driven chemical organizations?
Science-driven organizations face unique scaling challenges when embedding digital tools: domain expertise must coexist with software infrastructure, regulatory compliance adds complexity, and knowledge from distributed innovation centers requires systematic governance. Success depends on bridging chemistry expertise with scalable data and AI systems.
Why are chemical companies investing in digital coatings and formulation innovation?
Coatings and formulations are moving beyond protection to performance—driven by sustainability demands, regulatory pressures, and customer performance requirements. Digital tools enable real-time optimization of coating properties, predictive performance modeling, and faster adaptation to market shifts in automotive, industrial, and consumer applications.
How do chemistry expertise and tech entrepreneurship create value in specialty chemicals?
Chemists-turned-founders bring deep domain knowledge that identifies real problems tech alone cannot solve, while startup agility accelerates solution deployment. This combination proves especially powerful in niche markets like cosmetic ingredients and pharmaceutical formulations, where regulatory understanding and innovation speed are competitive advantages.
Discover Digital Chemical Playbook
DKSH Digital Team · Digital Chemical Playbook
▶ Listen to the podcast